Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke

NCT01674790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-03-23

No results posted yet for this study

Summary

The objective of the 'Exploring potential synergistic effects of aerobic exercise and cognitive training on cognition after stroke' pilot trial is to investigate the combined effects of aerobic and cognitive training on cognition after stroke. This is to lay the groundwork for a larger RCT on the same topic. Twenty patients greater than 6 months post-stroke will be randomly assigned into one of four following treatment groups: (i) aerobic training (AEROBIC group), (ii) cognitive training (COGNITIVE group), (iii) aerobic exercise plus cognitive training (AEROBIC+COGNITIVE group); and (iv) non-aerobic range of motion (ROM) and unstructured mental activity (CONTROL group) (for group descriptions, please see detailed description below). We hypothesize that the combination of aerobic exercise and cognitive training will be more effective in improving cognition after stroke than either treatment on its own.

Conditions

Interventions

BEHAVIORAL

Aerobic training

One 20-min session of body weight support treadmill training at moderate to high intensity (60-70% heart rate reserve) 5 days/week for 6-weeks.

BEHAVIORAL

Cognitive training

One 20-min session of cognitive training (computerized dual n-back training program) 5 days/week for 6 weeks.

BEHAVIORAL

Range of motion exercise

One 20-min session of range of motion exercise (non-aerobic passive and active movement of upper and lower extremity) 5 days/week for 6-weeks.

BEHAVIORAL

Unstructured mental activity

One 20-min session of unstructured mental activity (e.g., listening to light novels on tape) 5 days/week for 6-weeks.

Sponsors & Collaborators

  • Nova Scotia Health Research Foundation

    collaborator OTHER_GOV
  • Dalhousie University

    collaborator OTHER
  • Heart and Stroke Foundation of Canada

    collaborator OTHER
  • Marilyn MacKay-Lyons

    lead OTHER

Principal Investigators

  • Marilyn MacKay-Lyons, PhD · Dalhousie University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-13
Primary Completion
2017-06-16
Completion
2017-06-16

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01674790 on ClinicalTrials.gov